AcquisitionOther

Bolt Biotherapeutics, Inc. acquired Prana Therapies, Inc

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Bolt Biotherapeutics, Inc. -> Prana Therapies, Inc · $120 million

Following the acquisition, the Company will focus on advancing Prana’s pipeline of half-life-extended multispecific antibodies generated from its proprietary INSPIRE platform, led by PRA-216, a novel IL-4Rα/TSLP bispecific antibody currently in Phase 2 develop

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk